Back to catalogue
№ 327 20 filings · 2022-01-17 → 2026-07-29

SHAFTESBURY CAPITAL PLC

SHC
Real Estate Share price 147p Market cap £2.7bn Overall fit 340 /1000

High-quality REIT at a genuine discount with strong downside protection, but essentially zero AI-receiver exposure — the dominant screening criterion for this investor. Fair-to-cheap valuation and moderate operating leverage help; AI absence dominates.

Fair value range 190p–220p Mid case · £3.8bn
Absolute upside +39.2% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • Independent bi-annual RICS valuations (Knight Frank) anchor NAV at 223p
  • NBIM April 2025 purchase of 25% Covent Garden at book value validates asset marks
  • Fortress balance sheet (16% LTV) removes financial distress from the fair value bridge
Limits the call
  • Persistent sector NAV discount could delay or cap re-rating
  • Fair value range depends on assumed sustainable NAV discount, which is judgmental
Methodology

EPRA NTA with 10-15% discount, cross-checked vs net initial yield

In one line · bull case

Prime West End REIT trading at 35% NAV discount with 16% LTV, 28% embedded rental reversion, and a validating NBIM co-investment at book value.

In one line · biggest risk

Zero AI-receiver exposure means it fails the primary screen for this strategy, and the NAV discount could persist if UK real estate sentiment stays soft.

Drivers
AI beneficiary 8 /100
West End retail/F&B/office landlord — no direct AI revenue exposure; AI cited only as internal cyber/productivity risk.
Operating leverage 55 /100
Fixed cost base with ~28% embedded rental reversion; flow-through on incremental rent is high but total revenue capped by physical footprint.
Earnings vs expectations 60 /100
Consistently delivering inside or slightly above 5-7% ERV growth guidance; not enough sell-side data to judge vs consensus.
Growth momentum 60 /100
6-7% annualised ERV growth run-rate, 8% underlying EPS growth H1 2026, dividend up 16% — stable mid-single-digit compound.
Moat 75 /100
Aggregated, largely irreplaceable freehold ownership in prime West End districts with 35-year track record of ~4% rental growth.
Earnings quality 65 /100
Cash-converting underlying earnings clean; headline IFRS numbers include revaluation gains which can be lumpy.
Management quality 72 /100
Delivered merger integration ahead of cost targets, executed £574m NBIM partnership at NAV, growing dividend track record.
Cyclicality 60 /100
Prime central London real estate is cyclical but historically more defensive than secondary markets; retail/hospitality customer base adds sensitivity.
Leverage 20 /100
16% EPRA LTV, 100% fixed/hedged debt, ~£1bn liquidity, can withstand 54% valuation fall before covenant breach.

SHAFTESBURY CAPITAL PLC (SHC) — Investment Research Note

Executive summary

Shaftesbury Capital is the largest mixed-use REIT in London's West End, owning ~2.8m sq ft across Covent Garden, Carnaby|Soho and Chinatown (portfolio under management £5.6bn as at H1 2026). The trajectory since the 2023 Capco/Shaftesbury merger has been steadily positive — six consecutive halves of ERV growth (3.8% LFL in H1 2026), like-for-like valuation up 3.4% in H1 2026, underlying EPS up 8%, and a 16% dividend hike — helped by a low 16% LTV balance sheet and cost synergies (cost ratio down from >50% at merger to 32%). The most important point for valuation is the gap between the current share price (145p) and disclosed EPRA NTA of 223p; investors are being asked whether a ~35% NAV discount is warranted for a durably reversionary, low-leverage prime West End portfolio 2026-07-29 H1 report.

Fair value estimate

Methodology: NAV/NTA (primary) — the standard for prime REITs — cross-checked against net initial yield.

  • EPRA NTA: 223.1p (H1 2026); backed by independent Knight Frank valuations at 4.4% equivalent yield and 3.5% net initial yield 2026-07-29 H1 report.
  • Portfolio has ~28% reversion (£281m ERV vs £220m passing rent), providing embedded income growth without needing yield compression.
  • UK prime REITs typically trade at 5–20% discount to NAV in normal cycles; SHC's 35% discount is at the wide end of the historical range.
  • Fair value range: 190p – 220p per share (10–15% discount to NTA, in line with sector norms).
  • Implied market cap range: £3.5bn – £4.0bn (vs £2.65bn currently).
  • Midpoint: 205p / £3.75bn → +41% upside from 145p.

Sector context

  • Sector confirmed: Real Estate — UK REIT, prime central London mixed-use.
  • Quality/leverage profile: ABOVE typical peers. LTV of 16% is materially lower than most listed UK REITs (many run 25-35%); the West End concentration is a differentiator, not a diversification story.
  • Peers: Great Portland Estates (GPE), Derwent London (DLN), Workspace (WKP), Landsec/British Land at the larger cap end.

Investment thesis (3 bullets)

  1. Deep NAV discount for a durably compounding prime asset. Trading at ~35% below EPRA NTA of 223p despite the West End delivering ~4% CAGR rental growth over 35 years and 6.8% since 2010 2026-07-29 H1 report. Reversion of 28% (ERV vs passing rent) provides an embedded growth pipeline that doesn't require heroic macro assumptions.
  2. Fortress balance sheet in a rising-rate cycle. EPRA LTV of 16%, net debt/EBITDA of 6.4x, £980m of liquidity, 100% hedged/fixed debt, ability to withstand a 54% valuation fall before covenant breach — a rare position of financial strength 2026-07-29 H1 report.
  3. Endorsement by NBIM and merger execution. Norwegian sovereign wealth fund bought 25% of the Covent Garden estate at valuation (£574m gross) in April 2025 — a validating third-party mark. Cost ratio reduced from >50% at merger to 32%, and NTA has compounded 4.9% in H1 2026 alone (total accounting return) 2026-02-25 final results.

Key risks (3 bullets)

  1. Zero AI angle — pure real estate. For this specific investor thesis, SHC has no meaningful AI-receiver exposure. Retail, F&B, office and residential rents are not incremental beneficiaries of AI capex or agentic adoption. Any AI mentions in filings relate to cyber risk and internal productivity, not revenue 2026-07-29 H1 report principal risks.
  2. Concentrated in one London district — retail/leisure/hospitality dominant (~70% of ERV). A UK recession, sustained international-tourism decline, or an evolution in West End retail structure would hit valuations and rents (H1 2026 already shows retail is 15% below 2019 ERVs in real terms). Residential values ticking down (-0.2% H1 2026) 2026-07-29 H1 report.
  3. REIT re-rating requires macro cooperation. Discount to NAV persisted through 2024-2025 despite good operating results; if UK gilt yields stay elevated or property yields drift outwards further, the discount could persist or widen even as ERVs grow. Any income disruption from property management transition also flagged in H1 2026 2026-07-29 H1 report, ECL provision up to £2.8m.

Operating leverage

Operating leverage in SHC is REAL but bounded by lease structure. The cost base is largely fixed: property costs of ~£33m/yr and admin of ~£40m/yr against gross income of £219m — cost ratio 32%, targeting sub-30% 2026-02-25 final results, 2026-07-29 H1 report. Incremental rent from converting reversion drops mostly to profit: with 20% of ERV re-pricing annually and 28% reversionary uplift potential, each 1% of blended rental uplift adds roughly £2m of NOI at ~90% flow-through. However, incremental revenue is capped by physical portfolio (2.8m sq ft doesn't scale) and lease terms — this is NOT SaaS-style operating leverage where revenue is unconstrained. A 10-20% revenue surprise in one year is physically impossible; realistic upside is 5-7% pa rental growth compounding. The finance-cost line adds moderate gearing (£790m debt at 4.1% cost) — flat finance costs against growing NOI means underlying earnings could grow ~10-15% pa in a favourable scenario.

Value-trap signals

None identified. The disclosed metrics all point to a genuinely improving business: ERV rising, occupancy 97%+, leasing 18% ahead of previous passing rents, dividend up 16%, LTV falling, cost ratio falling, and a credible third-party validation (NBIM) at book value. This is not a cheap-because-broken situation — it is cheap because of sector-wide sentiment and the AI investor's aversion to real estate.

Earnings vs expectations

The filings do not disclose sell-side consensus explicitly, but SHC provides management medium-term targets of 5-7% rental growth and 8-10% total accounting return. Actual delivery: FY2025 like-for-like ERV +6.2%, total accounting return 9.1%; H1 2026 LFL ERV +3.8% (annualized ~7.6%), total accounting return 4.9% (annualized 9.8%). SHC has consistently landed inside or above its own guidance range across the four half-year reporting periods post-merger, with the interim dividend consistently raised (H1 2025: 1.9p → H1 2026: 2.2p, +16%). Pattern is one of consistent guidance delivery rather than material beats or misses.

Conviction

Conviction: 4 (high). REIT valuation is anchored by two independent inputs — external valuations from Knight Frank/CBRE and observable comparable transactions (NBIM's April 2025 purchase at book value). NAV per share is a hard number, not a modelled cash flow estimate.

  • Supporting factors: independent bi-annual valuations under RICS, transparent segment disclosure, comparable listed peers for cross-check, and NBIM validating the Covent Garden book value with real money.
  • Limiting factors: NAV discount could persist longer than modelled if UK real estate sentiment stays weak; the fair value range depends on the assumed discount to NAV, which is judgemental.

Filings consulted · 27

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-29Half Year Report2026-07-29_9692284_half-year-report.md0.90
  2. 2026-06-29Notice OF 2026 Interim Results2026-06-29_9641687_notice-of-2026-interim-results.md0.90
  3. 2026-05-14Result OF Agm2026-05-14_9569355_result-of-agm.md0.30
  4. 2026-05-14Agm Trading Update2026-05-14_9567535_agm-trading-update.md0.85
  5. 2026-04-092025 Final Dividend Exchange Rate2026-04-09_9512469_2025-final-dividend-exchange-rate.md0.30
  6. 2026-03-12Publication OF 2025 Annual Report And Agm Notice2026-03-12_9472116_publication-of-2025-annual-report-and-agm-notice.md0.95
  7. 2026-02-25Final Results2026-02-25_9445338_final-results.md1.00
  8. 2025-12-02Trading Update2025-12-02_9269014_trading-update.md0.72
  9. 2025-07-29Half Year Report2025-07-29_9007977_half-year-report.md0.58
  10. 2025-07-01Notice OF 2025 Interim Results2025-07-01_8957019_notice-of-2025-interim-results.md0.58
  11. 2025-05-22Agm Trading Update2025-05-22_8891271_agm-trading-update.md0.55
  12. 2025-03-13Publication OF 2024 Annual Report And Agm Notice2025-03-13_8778401_publication-of-2024-annual-report-and-agm-notice.md0.62
  13. 2025-02-27Final Results2025-02-27_8754571_final-results.md0.65
  14. 2024-11-26Trading Update2024-11-26_8572017_trading-update.md0.55
  15. 2024-07-31Half Year Report2024-07-31_8339644_half-year-report.md0.41
  16. 2024-07-01Notice OF 2024 Interim Results2024-07-01_8287030_notice-of-2024-interim-results.md0.41
  17. 2024-05-23Agm Trading Update2024-05-23_8215928_agm-trading-update.md0.38
  18. 2024-03-14Publication OF 2023 Annual Report And Agm Notice2024-03-14_8088676_publication-of-2023-annual-report-and-agm-notice.md0.43
  19. 2024-03-11Acquisition OF 25 31 James Street Covent Garden2024-03-11_8079731_acquisition-of-25-31-james-street-covent-garden.md0.34
  20. 2024-02-29Final Results2024-02-29_8062224_final-results.md0.45
  21. 2023-11-27Investor Event And Trading Update2023-11-27_7903671_investor-event-and-trading-update.md0.38
  22. 2023-03-28Notice OF Agm And Scrip Dividend Scheme2023-03-28_7339051_notice-of-agm-and-scrip-dividend-scheme.md0.07
  23. 2022-11-01Trading Update2022-11-01_7208816_trading-update.md0.21
  24. 2022-08-02Half Year Report2022-08-02_6956844_half-year-report.md0.23
  25. 2022-03-222021 Annual Report Amp Accounts And 2022 Agm Notice2022-03-22_7005466_2021-annual-report-amp-accounts-and-2022-agm-notice.md0.24
  26. 2022-02-23Final Results2022-02-23_6924255_final-results.md0.25
  27. 2022-01-17Trading Update2022-01-17_6856627_trading-update.md0.21

This research note was authored by a large language model after reading 20 regulatory filings published between 2022-01-17 and 2026-07-29. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.